 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
hydrolase activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
375:604-611
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form.
|
|
I.Garcia-Saez,
J.D.Docquier,
G.M.Rossolini,
O.Dideberg.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structures of the universally widespread metallo-beta-lactamase
(MBL) Verona integron-encoded MBL (VIM)-2 from Pseudomonas aeruginosa have been
solved in their native form as well as in an unexpected oxidised form. This
carbapenem-hydrolysing enzyme belongs to the so-called B1 subfamily of MBLs and
shares the folding of alpha beta/beta alpha sandwich, consisting of a core of
beta-sheet surrounded by alpha-helices. Surprisingly, it showed a high tendency
to be strongly oxidised at the catalytic cysteine located in the Cys site,
Cys221, which, in the oxidised structure, becomes a cysteinesulfonic residue.
Its native structure was obtained only in the presence of
Tris(2-carboxyethyl)phosphine. This oxidation might be a consequence of a lower
affinity for the second Zn located in the Cys site that would also explain the
observed susceptibility of VIM-2 to chelating agents. This modification, if
present in nature, might play a role in catalytic down-regulation. Comparison
between native and oxidised VIM-2 and a predicted model of VIM-1 (which shows
one residue different in the Cys site compared with VIM-2) is performed to
explain the different activities and antibiotic specificities.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Stereo view of the active site (His and Cys sites) of
(a) VIM-2 and (b) oxidised VIM-2. Contacts between the Zn ions
and Cys221 [in (a)] or Ocs221 [in (b)] with residues of the
active site (< 3.5 Å) are depicted. Water molecules are
shown as red spheres. The asterisk symbol indicates the position
of the two residues in VIM-2 (Tyr224 and Arg228) that are
different in VIM-1 (His224 and Ser228).
|
 |
Figure 3.
Fig. 3. Secondary structure of VIM-2 (in orange) and sequence
alignment with VIM-1 and VIM-3 variants. The residues labelled
in black and green are the differences between VIM-2 and VIM-1
and between VIM-2 and VIM-3, respectively. Residues labelled in
red belong to the His and Cys active sites. The asterisk symbol
indicates the position of the two residues that are different in
VIM-1 in comparison with VIM-2 in the Cys site.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2008,
375,
604-611)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Castanheira,
L.M.Deshpande,
R.E.Mendes,
E.Rodriguez-Noriega,
R.N.Jones,
and
R.Morfin-Otero
(2011).
Comment on: Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-{beta}-lactamases.
|
| |
J Antimicrob Chemother, 66,
684-685.
|
 |
|
|
|
|
 |
F.Robin,
N.Aggoune-Khinache,
J.Delmas,
M.Naim,
and
R.Bonnet
(2010).
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
|
| |
Antimicrob Agents Chemother, 54,
466-470.
|
 |
|
|
|
|
 |
J.M.Rodriguez-Martinez,
P.Nordmann,
N.Fortineau,
and
L.Poirel
(2010).
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
|
| |
Antimicrob Agents Chemother, 54,
471-476.
|
 |
|
|
|
|
 |
L.Borgianni,
J.Vandenameele,
A.Matagne,
L.Bini,
R.A.Bonomo,
J.M.Frère,
G.M.Rossolini,
and
J.D.Docquier
(2010).
Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
|
| |
Antimicrob Agents Chemother, 54,
3197-3204.
|
 |
|
|
|
|
 |
M.Merino,
F.J.Pérez-Llarena,
F.Kerff,
M.Poza,
S.Mallo,
S.Rumbo-Feal,
A.Beceiro,
C.Juan,
A.Oliver,
and
G.Bou
(2010).
Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
|
| |
J Antimicrob Chemother, 65,
1950-1954.
|
 |
|
|
|
|
 |
P.Oelschlaeger,
N.Ai,
K.T.Duprez,
W.J.Welsh,
and
J.H.Toney
(2010).
Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
|
| |
J Med Chem, 53,
3013-3027.
|
 |
|
|
|
|
 |
Y.Yamaguchi,
N.Takashio,
J.Wachino,
Y.Yamagata,
Y.Arakawa,
K.Matsuda,
and
H.Kurosaki
(2010).
Structure of metallo-beta-lactamase IND-7 from a Chryseobacterium indologenes clinical isolate at 1.65-A resolution.
|
| |
J Biochem, 147,
905-915.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Bebrone,
H.Delbrück,
M.B.Kupper,
P.Schlömer,
C.Willmann,
J.M.Frère,
R.Fischer,
M.Galleni,
and
K.M.Hoffmann
(2009).
The structure of the dizinc subclass B2 metallo-beta-lactamase CphA reveals that the second inhibitory zinc ion binds in the histidine site.
|
| |
Antimicrob Agents Chemother, 53,
4464-4471.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Minond,
S.A.Saldanha,
P.Subramaniam,
M.Spaargaren,
T.Spicer,
J.R.Fotsing,
T.Weide,
V.V.Fokin,
K.B.Sharpless,
M.Galleni,
C.Bebrone,
P.Lassaux,
and
P.Hodder
(2009).
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.
|
| |
Bioorg Med Chem, 17,
5027-5037.
|
 |
|
|
|
|
 |
D.Yong,
M.A.Toleman,
C.G.Giske,
H.S.Cho,
K.Sundman,
K.Lee,
and
T.R.Walsh
(2009).
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
|
| |
Antimicrob Agents Chemother, 53,
5046-5054.
|
 |
|
|
|
|
 |
I.Schneider,
E.Keuleyan,
R.Rasshofer,
R.Markovska,
A.M.Queenan,
and
A.Bauernfeind
(2008).
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
|
| |
Antimicrob Agents Chemother, 52,
2977-2979.
|
 |
|
|
|
|
 |
P.Marchiaro,
P.E.Tomatis,
M.A.Mussi,
F.Pasteran,
A.M.Viale,
A.S.Limansky,
and
A.J.Vila
(2008).
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
|
| |
Antimicrob Agents Chemother, 52,
2250-2252.
|
 |
|
|
|
|
 |
Ã.˜.Samuelsen,
M.Castanheira,
T.R.Walsh,
and
J.Spencer
(2008).
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
|
| |
Antimicrob Agents Chemother, 52,
2905-2908.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|